PPP1R14C and breast carcinoma: The expression and clinical significance of PPP1R14C were then assessed by immunohistochemistry (IHC) and survival analysis in 150 breast cancer patient specimens, including 50 non‐TNBCs and 100 TNBCs (Supplementary Table 2).